Funding

The Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia (A&AA), as the leading medical and patient support organisations for allergy in Australia, developed the first National Allergy Strategy for Australia, in collaboration with other stakeholder organisations. ASCIA and A&AA greatly appreciate the funding support that has enabled the development and initial implementation of the National Allergy Strategy.

The National Allergy Strategy has now transitioned to the National Allergy Council, who will continue to implement the Strategy.

Development of the National Allergy Strategy

While funding from the Australian Government Department of Health has supported implementation since 2015, development of the National Allergy Strategy, including two Allergy Summits was funded by unrestricted education grants obtained by ASCIA. These grants were from the following organisations:

Major supporters:

  • Mylan (formerly Alphapharm)
  • Seqirus (formerly bioCSL)
  • Stallergenes Greer
  • Bayer

Other supporters:

  • Nutricia
  • Nestlé Nutrition
  • Merck Sharp & Dohme

It is important to note that the content of both the Allergy Summits and the National Allergy Strategy has been independently developed and has not been influenced by organisations that have provided unrestricted educational grants.

Implementation of the National Allergy Strategy

Government funding

  • Australian Government Department of Health
  • Australian Digital Health Agency

Unrestricted education grants

The following organisations provided unrestricted education grants to help implement the National Allergy Strategy projects:

Major supporters:

  • PCH Foundation
  • GSK
  • Mylan
  • Sanofi
  • Abbott
  • Allergy Concepts
  • Nutricia
  • Bayer

Other supporters:

  • DBV Technologies
  • Stallergenes Greer
  • Abacus dx
  • Nestle Nutrition

It is important to note that the implementation of the National Allergy Strategy has not been influenced by organisations that have provided unrestricted educational grants.

Private donations

  • The National Allergy Strategy has received private donations from families and ASCIA members to help implement the National Allergy Strategy

Content updated August 2022

The National Allergy Council remains a partnership between ASCIA and Allergy & Anaphylaxis Australia and continues to implement the National Allergy Strategy.

National Allergy Strategy
Rationale

Allergic diseases have become an increasingly important chronic disease and public health issue in Australia and other developed countries over the last two decades, contributing to increased demand for medical services, significant economic cost of care and reduced quality of life of people with allergic diseases and their carers.

Information
Partner

healthdirect: 
trusted health information
Funded by the governments of Australia

Lead organisations

ascia logo 2018s
Australasian Society of Clinical Immunology and Allergy (ASCIA) is the leading medical organisation for allergy in Australia. 

aaa logo 2018s
Allergy & Anaphylaxis Australia (A&AA) is the leading patient support organisation for allergy in Australia. 

The National Allergy Strategy has received funding from the Australian Government Department of Health for the following projects:
Food allergy prevention | 250K Youth Project | Food service | Drug allergy | Shared Care Model

© National Allergy Strategy Aug 2015 | Contact Us | Disclaimer | Food Allergy Training Help | Privacy | Sitemap

Acknowledgement of Country
The National Allergy Council acknowledges the Traditional Custodians of the land upon which we are located. We pay our respect to their Elders past, present and emerging.